文献速递环境卫生慢病防控与筛查

他汀使用状态对细颗粒物(PM2.5)与心血管死亡关联的效应修饰作用

Effect modification by statin use status on the association between fine particulate matter (PM2.5) and cardiovascular mortality.
PubMed 文献 · Int J Epidemiol · 2024-01-01

BACKGROUND: Numerous studies have linked fine particulate matter (PM2.5) to increased cardiovascular mortality. Less is known how the PM2.5-cardiovascular mortality association varies by use of cardiovascular medications.…

要点

  • 长期PM2.5暴露升高心血管、冠心病和卒中死亡风险。
  • 他汀非使用者中PM2.5与心血管死亡关联强于使用者。
  • 他汀使用者中部分依从者PM2.5相关死亡风险高于完全依从者。

核心结论

  • 长期PM2.5暴露与心血管死亡和冠心病死亡的关联在他汀非使用者中强于使用者。

研究设计与样本

  • 病例为死于心血管、冠心病或卒中的患者,每个病例按发病密度抽样个体匹配至多30名随机对照。
  • 采用条件logistic回归估计PM2.5与死亡关联的比值比(OR),并从乘性(OR比值)和加性(交互作用相对超额风险,RERI)尺度评估效应修饰。

主要发现

  • PM2.5暴露升高心血管、冠心病和卒中死亡风险。
  • 心血管死亡:PM2.5每升高一个四分位间距,他汀非使用者OR=1.042(95%CI 1.032-1.053)vs 使用者OR=1.009(95%CI 0.996-1.022),OR比值=1.033(95%CI 1.019-1.047),RERI=0.039(95%CI 0.025-0.050)。
  • 三种死因均观察到非使用者中PM2.5-死亡关联强于使用者。
  • 使用者中,部分依从者PM2.5相关死亡风险高于完全依从者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous studies have linked fine particulate matter (PM2.5) to increased cardiovascular mortality. Less is known how the PM2.5-cardiovascular mortality association varies by use of cardiovascular medications. This study sought to quantify effect modification by statin use status on the associations between long-term exposure to PM2.5 and mortality from any cardiovascular cause, coronary heart disease (CHD), and stroke. METHODS: In this nested case-control study, we followed 1.2 million community-dwelling adults aged ≥66 years who lived in Ontario, Canada from 2000 through 2018. Cases were patients who died from the three causes. Each case was individually matched to up to 30 randomly selected controls using incidence density sampling. Conditional logistic regression models were used to estimate odds ratios (ORs) for the associations between PM2.5 and mortality. We evaluated the presence of effect modification considering both multiplicative (ratio of ORs) and additive scales (the relative excess risk due to interaction, RERI). RESULTS: Exposure to PM2.5 increased the risks for cardiovascular, CHD, and stroke mortality. For all three causes of death, compared with statin users, stronger PM2.5-mortality associations were observed among non-users [e.g. for cardiovascular mortality corresponding to each interquartile range increase in PM2.5, OR = 1.042 (95% CI, 1.032-1.053) vs OR = 1.009 (95% CI, 0.996-1.022) in users, ratio of ORs = 1.033 (95% CI, 1.019-1.047), RERI = 0.039 (95% CI, 0.025-0.050)]. Among users, partially adherent users exhibited a higher risk of PM2.5-associated mortality than fully adherent users. CONCLUSIONS: The associations of chronic exposure to PM2.5 with cardiovascular and CHD mortality were stronger among statin non-users compared to users.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Bai L, Kwong JC, Kaufman JS, et al. Effect modification by statin use status on the association between fine particulate matter (PM2.5) and cardiovascular mortality. Int J Epidemiol. 2024. PMID: 38961644. doi:10.1093/ije/dyae084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。